{"id":"W4310275920","doi":"10.1007/s13555-022-00853-4","title":"Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program","year":2022,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada); SKiN Health; Memorial University of Newfoundland","funders":"Eli Lilly Canada; Eli Lilly and Company","keywords":"Ixekizumab; Plaque psoriasis; Persistence (discontinuity); Medicine; Psoriasis; Physical therapy; Dermatology; Psoriatic arthritis; Engineering; Secukinumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009039701,0.0001634009,0.0002869228,0.0001741945,0.0003107961,0.000007210044,0.0001246572,0.00009727728,0.0001428731],"category_scores_gemma":[0.000004618758,0.0001088602,0.00003842365,0.0002277404,0.00009299546,0.00003450595,0.00001815335,0.000131324,0.000004861183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008383618,"about_ca_system_score_gemma":0.0001832431,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01705564,"about_ca_topic_score_gemma":0.1059751,"domain_scores_codex":[0.9986663,0.0004433733,0.0002345805,0.000251847,0.00003862847,0.0003652039],"domain_scores_gemma":[0.999605,0.00009463547,0.000071232,0.0001779673,0.00002046209,0.00003070717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00880306,0.001843158,0.443994,0.00002562651,0.0004636734,0.0008237583,0.107865,0.0003960059,0.0001524961,0.0009490327,0.0001805838,0.4345036],"study_design_scores_gemma":[0.08351503,0.03453686,0.6364966,0.0002160732,0.0003592495,0.01271016,0.08268448,0.0005486406,0.03434443,0.0006759032,0.1115935,0.002319035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964233,0.001208425,4.572514e-7,0.0009545324,0.00008431528,0.0007914217,0.00006477591,0.00001260074,0.0004601504],"genre_scores_gemma":[0.9968944,0.0001585924,0.00004651951,0.0003197889,0.000002846995,0.002450697,0.00009763087,0.00000868886,0.00002088048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4321845,"threshold_uncertainty_score":0.9894899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02245852899902205,"score_gpt":0.2391384421415881,"score_spread":0.216679913142566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}